Review
Open access
Sep 2026
Efficacy and safety of daratumumab-based quadruplet therapy vs non-daratumumab-based triplet therapy in newly diagnosed multiple myeloma patients: A GRADE assessed systematic review and meta-analysis of randomized controlled trials
The meta-analysis shows higher efficacy yet higher adverse events in Daratumumab-based quadruplet therapy for NDMM patients (TE, and TIE).
M. Osama, Muhammad Haris Khan, Ammara Tahir et al.
· Therapeutic Advances in Hema... · 0 citations